GENEDRIVE PLC ORD 1.5P chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 0.00
Dividend & YieldN/A£ (N/A)
Beta 0
Market capitalization 11.89M
Operating cash flow -3.92M
ESG Scores unknown

Company description

genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. The company provides Genedrive, a patented small polymerase chain reaction, which enables rapid nucleic acid amplification and detection from various sample types, including plasma, sputum, and buccal swabs. Its Genedrive platform offers Genedrive HCV ID Kit, a qualitative molecular solution for Hepatitis C Virus testing; Genedrive BioPlex for the rapid determination of military biothreats from pathogens; Genedrive MT-RNR1-ID Kit, a rapid genetic test in an emergency neonatal care setting; and Genedrive Connect app, an android-based mobile app that allows added data management flexibility and results transmission. The company serves biotechnology and pharmaceutical industries in the United Kingdom, Europe, the United States, and internationally. It has a collaboration agreement with Beckman Coulter Life Sciences to automate the laboratory PCR testing process for COVID-19. The company was formerly known as Epistem Holdings Plc and changed its name to genedrive plc in July 2016. genedrive plc was founded in 2000 and is headquartered in Manchester, the United Kingdom.

Sector: Healthcare - Industry: Diagnostics & Research

Financial data

Financial Statements

Cashflow Statement 2018-06-30 2019-06-30 2020-06-30 2021-06-30
Change To Liabilities -662k -258k 979k -1.03M
Total Cashflows From Investing Activities 946k -23k -42k 1k
Net Borrowings 2.37M 2.37M -685k -502k
Total Cash From Financing Activities 5.31M 5.31M 6.86M -456k
Change To Operating Activities
Issuance Of Stock 3.24M 3.24M 7.55M 46k
Net Income -5.97M -3.64M -19.42M -691k
Change In Cash -1.6M 1.66M 3.03M -5.64M
Effect Of Exchange Rate 1k -10k 1k -37k
Total Cash From Operating Activities -2.55M -3.62M -3.79M -5.15M
Depreciation 1.01M 98k 57k 246k
Change To Account Receivables 119k 60k 158k 240k
Other Cashflows From Financing Activities -300k -300k
Change To Netincome 2.72M 127k 14.73M -3.77M
Capital Expenditures -24k -97k -40k -104k

Income Statement 2018-06-30 2019-06-30 2020-06-30 2021-06-30
Research Development
Income Before Tax -7.79M -4.52M -20.38M -1.85M
Net Income -5.97M -3.64M -19.42M -691k
Selling General Administrative 2.02M 1.93M 2.03M 1.66M
Gross Profit -3.24M -2.52M -3.61M -3.82M
Ebit -5.26M -4.45M -5.64M -5.48M
Operating Income -5.26M -4.45M -5.64M -5.48M
Interest Expense -531k -889k -808k -235k
Income Tax Expense -758k -882k -965k -1.16M
Total Revenue 1.94M 2.36M 1.06M 687k
Cost Of Revenue 5.18M 4.88M 4.67M 4.51M
Total Other Income ExpenseNet -2.52M -69k -14.74M 3.63M
Net Income From Continuing Ops -7.03M -3.64M -19.42M -691k
Net Income Applicable To Common Shares -5.97M -3.64M -19.42M -691k

Balance Sheet Statement 2018-06-30 2019-06-30 2020-06-30 2021-06-30
Total Liabilities 8.35M 9.73M 13.79M 1.28M
Total Stockholder Equity -2.44M -2.48M -3.34M 3.59M
Other Current Liabilities 1.44M 204k 351k 195k
Total Assets 5.91M 7.26M 10.45M 4.88M
Common Stock 282k 510k 780k 950k
Other Current Assets 172k 106k 212k 75k
Retained Earnings -27.46M -31.1M -46.74M -42.36M
Treasury Stock -1.24M -891k -1.06M -1.05M
Cash 3.53M 5.18M 8.22M 2.57M
Total Current Liabilities 2.72M 1.22M 2.2M 1.28M
Other Stockholder Equity -1.24M -891k -1.06M -1.05M
Property, Plant, and Equipment 165k 164k 147k 301k
Total Current Assets 5.4M 6.94M 10.26M 4.53M
Net Tangible Assets -2.44M -2.48M -3.34M 3.59M
Net Receivables 1.27M 1.34M 1.29M 1.18M
Accounts Payable 392k 402k 980k 439k


Insider Transactions

Here are the insider transactions of stock shares related to GENEDRIVE PLC ORD 1.5P:

Filer Name Transaction Text Ownership Date Filer Relation Shares
Fowler (Matthew Allen)Exercise of Option at price 0.40 per share.D2022-04-08264.05k
Fowler (Matthew Allen)Sold at price 0.24 per share.D2022-02-2386.96k
Fowler (Matthew Allen)D2021-12-20
Calculus Capital LtdD2021-12-171.46M
Budd (David)D2021-11-08
Fowler (Matthew Allen)D2021-11-08
Gilham (Ian David)D2021-11-08
Lindsay (Tom)D2021-11-08
Yates (Christopher Henry Francis)D2021-11-08
Yates (Christopher Henry Francis)Bought at price 0.34 per share.D2021-09-2820k
Lindsay (Tom)Bought at price 0.34 per share.D2021-09-2860k
Budd (David)Bought at price 0.34 per share.D2021-09-2880k
Fowler (Matthew Allen)Bought at price 0.34 per share.D2021-09-2840k
Gilham (Ian David)Bought at price 0.34 per share.D2021-09-28111.12k
Budd (David)D2021-06-30
Calculus Capital LtdD2021-06-30
Fowler (Matthew Allen)D2021-06-30
Gilham (Ian David)D2021-06-30
Lindsay (Tom)D2021-06-30
Yates (Christopher Henry Francis)D2021-06-30
Global Health Investment Co., Ltd.D2021-02-112.9M
Calculus Capital LtdD2021-02-09802.5k
Calculus Capital LtdD2021-02-08310k
BGF Investment Management, Ltd.D2021-01-291.95M
BGF Investment Management, Ltd.D2021-01-221.35M
BGF Investment Management, Ltd.D2021-01-15500k
BGF Investment Management, Ltd.D2020-12-22625k
BGF Investment Management, Ltd.D2020-12-16
Calculus Capital LtdD2020-12-16

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to GENEDRIVE PLC ORD 1.5P. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on GENEDRIVE PLC ORD 1.5P

Here is the result of two systematic investment strategies applied to GENEDRIVE PLC ORD 1.5P. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on GENEDRIVE PLC ORD 1.5P

The following chart shows the equity curve of the two systematic investment strategies applied to GENEDRIVE PLC ORD 1.5P:

GENEDRIVE PLC ORD 1.5P automated entries

The systematic investment strategy that buys the first day of the month would give a performance of -72.06% on the backtest period.

Performance at glance

Performance

-72.06 %

Latent gain

-472.0 £

Invested capital

655.0 £

Annualized return

-47.41 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on GENEDRIVE PLC ORD 1.5P

This is the result of two momentum investment strategies applied to GENEDRIVE PLC ORD 1.5P. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on GENEDRIVE PLC ORD 1.5P

The following chart shows all the entries opened by the momentum investment system on GENEDRIVE PLC ORD 1.5P:

GENEDRIVE PLC ORD 1.5P momentum entries
  • The first momentum investment strategy would give -67.09% of return on GENEDRIVE PLC ORD 1.5P. That represents -858.1£ of latent gain with 1279.0£ of employed capital.
  • The second momentum investment strategy would give -68.72% of return on GENEDRIVE PLC ORD 1.5P. That represents -1085.4£ of latent gain with 1579.5£ of employed capital.
Performance at glance (1Q Momentum)

Performance

-67.09 %

Latent gain

-858.1 £

Invested capital

1279.0 £

Annualized return

-0.0 %
Performance at glance (2Q Momentum)

Performance

-68.72 %

Latent gain

-1085.4 £

Invested capital

1579.5 £

Annualized return

-66.08 %

Momentum equity curve on GENEDRIVE PLC ORD 1.5P

The following chart shows the equity curve of the two momentum strategies applied to GENEDRIVE PLC ORD 1.5P:

GENEDRIVE PLC ORD 1.5P momentum equity

Note: the dividends potentially given by GENEDRIVE PLC ORD 1.5P are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on GENEDRIVE PLC ORD 1.5P

The following chart shows the employed capital evolution of the two momentum strategies on GENEDRIVE PLC ORD 1.5P since the beginning:

GENEDRIVE PLC ORD 1.5P

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250£, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000£.


Buy the dip strategy result on GENEDRIVE PLC ORD 1.5P

Buy the dip entry openings on GENEDRIVE PLC ORD 1.5P

GENEDRIVE PLC ORD 1.5P

The performance achieved by the robo-advisor on GENEDRIVE PLC ORD 1.5P is 0%. That represents 0.0$ of latent gain with 0.0£ of employed capital. The following chart shows GENEDRIVE PLC ORD 1.5P stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of GENEDRIVE PLC ORD 1.5P, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

0 %

Latent gain

0.0 £

Invested capital

0.0 £

Annualized return

-0.0 %

Equity curve of the strategy applied to GENEDRIVE PLC ORD 1.5P

The following chart shows the result of the investment strategy applied to GENEDRIVE PLC ORD 1.5P:

GENEDRIVE PLC ORD 1.5P

Note: the dividends potentially given by GENEDRIVE PLC ORD 1.5P are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on GENEDRIVE PLC ORD 1.5P

The following chart shows the employed capital evolution since the beginning of the investment strategy on GENEDRIVE PLC ORD 1.5P:

GENEDRIVE PLC ORD 1.5P

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on GENEDRIVE PLC ORD 1.5P

In this section, I will compare the three previous investment strategies applied to GENEDRIVE PLC ORD 1.5P.

Equity curve comparison on GENEDRIVE PLC ORD 1.5P

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

GENEDRIVE PLC ORD 1.5P investment strategy comparison

Employed capital comparison on GENEDRIVE PLC ORD 1.5P

GENEDRIVE PLC ORD 1.5P investment comparison

Performance comparison on GENEDRIVE PLC ORD 1.5P

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment -72.06% -472.0£ 655.0£ -47.41%
Momentum 1 quarter -67.09% -858.1£ 1279.0£ -52.41%
Momentum 2 quarters -68.72% -1085.4£ 1579.5£ -66.08%
Non-directional 0% 0.0£ 0.0£ -0.0%
Annualized return comparison

Automatic investment

-47.41 %

Momentum 1Q

-66.08 %

Momentum 2Q

-66.08 %

Non-directional

-0.0 %

Correlated stocks

Here are the most positively and negatively correlated stocks with GENEDRIVE PLC ORD 1.5P:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between GENEDRIVE PLC ORD 1.5P and the other stocks. There may be false positives or some missing correlated stocks. If the price of GENEDRIVE PLC ORD 1.5P does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name GENEDRIVE PLC ORD 1.5P
Country United Kingdom
City Manchester
Address The CTF Building
Phone 44 16 1989 0245
Website www.genedriveplc.com
FullTime employees 46
Industry Diagnostics & Research
Sector Healthcare
Exchange XLON
Ticker GDR.XLON
Market www.londonstockexchange.com

GENEDRIVE PLC ORD 1.5P ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown